Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Update

Jaguar Health, Inc. (NASDAQ:JAGX) was the recipient of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 785,100 shares, a growth of 32.5% from the January 15th total of 592,700 shares. Currently, 7.9% of the shares of the company are sold short. Based on an average trading volume of 436,600 shares, the short-interest ratio is presently 1.8 days.

Institutional Investors Weigh In On Jaguar Health

A hedge fund recently raised its stake in Jaguar Health stock. Geode Capital Management LLC raised its position in Jaguar Health, Inc. (NASDAQ:JAGX) by 18.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 96,716 shares of the biotechnology company’s stock after buying an additional 14,895 shares during the period. Geode Capital Management LLC owned about 0.82% of Jaguar Health worth $98,000 as of its most recent filing with the SEC. Institutional investors own 12.04% of the company’s stock.

Jaguar Health Trading Up 5.3 %

JAGX traded up $0.04 on Friday, hitting $0.90. 358,118 shares of the stock traded hands, compared to its average volume of 329,583. Jaguar Health has a 52 week low of $0.78 and a 52 week high of $21.60. The company has a current ratio of 1.84, a quick ratio of 1.36 and a debt-to-equity ratio of 1.65. The business has a fifty day moving average price of $0.95 and a two-hundred day moving average price of $1.06.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.